222 related articles for article (PubMed ID: 34181324)
1. ABO Blood Groups and Its Association with Oral Cancer, Oral Potentially Malignant Disorders and Oral Submucous Fibrosis- A Systematic Review and Meta-Analysis.
Singh A; Purohit BM
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1703-1712. PubMed ID: 34181324
[TBL] [Abstract][Full Text] [Related]
2. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
3. Is there an association between oral submucous fibrosis and ABO blood grouping?
Gopal Reddy VK; Moon NJ; Sharva V; ; Reddy EK; Chandralkala S
J Cancer Res Ther; 2016; 12(1):126-30. PubMed ID: 27072224
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Platelet Parameters in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma in a Background of Oral Submucous Fibrosis.
Ranjitham PS; Kuzhali S; Sumathy MP; Gnandeepam S
Indian J Dent Res; 2023 Oct; 34(4):417-421. PubMed ID: 38739824
[TBL] [Abstract][Full Text] [Related]
5. Salivary LDH in oral cancer and potentially malignant disorders: A systematic review and meta-analysis.
Iglesias-Velázquez Ó; López-Pintor RM; González-Serrano J; Casañas E; Torres J; Hernández G
Oral Dis; 2022 Jan; 28(1):44-56. PubMed ID: 32881152
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis.
Mello FW; Miguel AFP; Dutra KL; Porporatti AL; Warnakulasuriya S; Guerra ENS; Rivero ERC
J Oral Pathol Med; 2018 Aug; 47(7):633-640. PubMed ID: 29738071
[TBL] [Abstract][Full Text] [Related]
7. Serum Lactate Dehydrogenase Enzyme as a Tumor Marker in Potentially Malignant Disorders: A Systematic Review and Meta-Analysis.
Barbi W; Purohit BM
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2553-2559. PubMed ID: 36037107
[TBL] [Abstract][Full Text] [Related]
8. Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders.
Pokala A; Paramkusam G; Tejaswi MLA; Bangi BB; Nadendla LK; Devulapally RV
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1163-1166. PubMed ID: 32334486
[TBL] [Abstract][Full Text] [Related]
9. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
10. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
11. Plasma non-enzymatic antioxidants-vitamin C, E, beta-carotenes, reduced glutathione levels and total antioxidant activity in oral sub mucous fibrosis.
Bose KS; Vyas P; Singh M
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):530-2. PubMed ID: 22696882
[TBL] [Abstract][Full Text] [Related]
12. Determination of role of ceruloplasmin in oral potentially malignant disorders and oral malignancy-A cross-sectional study.
Shah PH; Venkatesh R; More CB
Oral Dis; 2017 Nov; 23(8):1066-1071. PubMed ID: 28513913
[TBL] [Abstract][Full Text] [Related]
13. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
Coletta RD; Salo T
Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603
[TBL] [Abstract][Full Text] [Related]
14. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
Varghese I; Sugathan CK; Balasubramoniyan G; Vijayakumar T
Oncology; 1987; 44(4):224-7. PubMed ID: 3614812
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
[TBL] [Abstract][Full Text] [Related]
16. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan.
Tsai KY; Su CC; Chiang CT; Tseng YT; Lian IB
Cancer Epidemiol; 2017 Apr; 47():118-124. PubMed ID: 28259083
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Oral Submucous Fibrosis With Other Oral Potentially Malignant Disorders: A Clinical Retrospective Study.
S S; R S
Cureus; 2023 Nov; 15(11):e49642. PubMed ID: 38161840
[TBL] [Abstract][Full Text] [Related]
18. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
19. Estimation of serum beta carotene levels in patients with oral submucous fibrosis in India.
Aggarwal A; Shetti A; Keluskar V; Bagewadi A
J Oral Sci; 2011 Dec; 53(4):427-31. PubMed ID: 22167026
[TBL] [Abstract][Full Text] [Related]
20. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
